Armata Pharmaceuticals (ARMP) EPS (Weighted Average and Diluted) (2013 - 2026)
Armata Pharmaceuticals' (ARMP) quarterly EPS (Weighted Average and Diluted) came in at -$3.16 in Q1 2026, down 1480.0% year-on-year from $0.23 in Q1 2025, and up 7.87% quarter-over-quarter from -$3.43 in Q4 2025.
Armata Pharmaceuticals (ARMP) EPS (Weighted Average and Diluted) (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals has disclosed EPS (Weighted Average and Diluted) across 14 years of filings, most recently posting -$3.16 for Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$3.16, down 1480.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.78 (down 774.16% YoY), and the FY2025 annual result was -$4.8, down 439.33% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$3.16 for Q1 2026 at Armata Pharmaceuticals, up from -$3.43 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.15 in Q3 2024 to a low of -$3.43 in Q4 2025.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.3 (2022), against an average of -$0.73.
- Across the five-year window, EPS (Weighted Average and Diluted) surged 82.56% in 2024 and slumped 1480.0% in 2026, its largest moves.
- Armata Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$0.29 in 2022, then tumbled by 89.66% to -$0.55 in 2023, then soared by 47.27% to -$0.29 in 2024, then sank by 1082.76% to -$3.43 in 2025, then increased by 7.87% to -$3.16 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$3.16 (Q1 2026), -$3.43 (Q4 2025), and -$0.74 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 0.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -0.61 |
| 10 | Armata Pharmaceuticals | 275.44 Mn | 270.68 Mn | - | -3.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.16 |
| Dec 31, 2025 | -3.43 |
| Sep 30, 2025 | -0.74 |
| Jun 30, 2025 | -0.45 |
| Mar 31, 2025 | -0.20 |
| Dec 31, 2024 | -0.29 |
| Sep 30, 2024 | -0.15 |
| Jun 30, 2024 | -0.25 |
| Mar 31, 2024 | -0.69 |
| Dec 31, 2023 | -0.55 |
| Sep 30, 2023 | -0.86 |
| Jun 30, 2023 | -0.17 |
| Mar 31, 2023 | -0.40 |
| Dec 31, 2022 | -0.29 |
| Sep 30, 2022 | -0.24 |
| Jun 30, 2022 | -0.26 |
| Mar 31, 2022 | -0.30 |
| Dec 31, 2021 | -0.23 |
| Sep 30, 2021 | -0.22 |
| Jun 30, 2021 | -0.25 |